EarWay (866945)

  https://cordis.europa.eu/project/id/866945

  Horizon 2020 (2014-2020)

  EarWay: a simple, safe and efficient medical device for earwax removal

  SME instrument (EIC-SMEInst-2018-2020)

  innovation management  ·  otorhinolaryngology

  2019-05-01 Start Date (YY-MM-DD)

  2019-08-31 End Date (YY-MM-DD)

  € 71,429 Total Cost

  Description

Approximately 1.1bn (15%) of the people worldwide suffer from recurrent cerumen impaction, being the 1st reason worldwide of treatable hearing loss. Impacted earwax can cause uncountable symptoms ranging from ear pain, itching, ringing (tinnitus) and discharge/odour to more severe diseases like hearing loss and eventually depression, paranoia, impaired cognition and speech disorders, and consequently social isolation. Current professional tools are complex and slow: many of these methods (e.g., irrigation) cause patient discomfort and are associated to treatments that are long (15-40 minutes) and often complex (e.g, micro suction) therefore not viable for General Practitioners and only allowed for the scarce Ear Nose and Throat specialists (ENT´s) associated with long waiting times for patients. To solve this, healthcare organizations are promoting the empowerment of patients via the shift to homecare solutions. Based on an innovative “release with a twist” principle, the products EarWay®Pro and EarWay®HomeCare are designed to enable simple cerumen extraction and management of earwax impaction. Their background technology provides safe, effective (87% success) and fast (90% reduced treatment time) devices that have been clinically validated in 200 successful earwax removal cases by both primary carers ) and specialists. Moreover they return the power to the primary-care professionals (EarWay®Pro) and the patient (EarWay®HomeCare) ultimately reducing the burden for the healthcare system. EarWay® products are targeting a large market of €7.3 billion in Europe and USA alone, including a €5.8 billion HomeCare market represented by over 122 million cerumen-impacted people and the €1.5-billion Pro market with over 900,000 target physicians. EARWAYS MEDICAL LTD. is a leading innovator of ear-care solutions. Founded to enhance the well-being of millions of children and adults worldwide, providing easy-to-use ear-care products for both clinicians and home use.

  Complicit Organisations

1 Israeli organisation participates in EarWay.